Abstract
Metabolism of pyridalyl [2,6-dichloro-4-(3,3-dichloroallyloxy)phenyl 3-[5-(trifluoromethyl)-2-pyridyloxy]propyl ether] was examined in male and female Sprague-Dawley rats. After a single oral administration of [dichlorophenyl-14C]pyridalyl at 5 or 500 mg/kg, the 14C concentration in blood reached maxima at 2 to 10 h and then decreased rapidly with a biological half-life of approximately 11 to 12 h. 14C concentrations in liver, fat, adrenal gland, and spleen were relatively high at a low dose, reaching 2.3 to 2.7, 1.9 to 2.3, 1.1 to 1.9, and 1.4 ppm, respectively, in these tissues at 2 to 24 h after administration. Although 14C elimination from fat and hair and skin was relatively slow compared with that from other tissues, the total residue on the 7th day was low, in the range of 1.3 to 2.3% of the dose. The 14C distribution in tissues with a high dose, as examined by whole-body autoradiography, was similar to that observed for the low dose. Results revealed that more than 88% of the dosed radiocarbon was excreted within 1 day after administration, with cumulative 14C excretion into urine and feces 7 days after administration of 1.7 to 2.6 and 98.7 to 101.7%, respectively. One urinary and fecal major metabolite (resulting from O-dealkylation) and two minor metabolites were identified by NMR and mass spectrometry. Residual 14C in fat was extracted, and analysis by thin-layer chromatography showed it to be due to pyridalyl itself. No marked sex-related differences were observed in 14C elimination, 14C distribution, and metabolites.
Footnotes
-
Article, publication date, and citation information can be found at http://dmd.aspetjournals.org.
doi:10.1124/dmd.109.028878
-
- S-1812
- 2,6-dichloro-4-(3,3-dichloroallyloxy)phenyl 3-[5-(trifluoromethyl)-2-pyridyloxy]propyl ether
- TLC
- thin-layer chromatography
- FAB
- fast atom bombardment
- MS
- mass spectrometry
- HPLC
- high-performance liquid chromatography
- LSC
- liquid scintillation counting
- EI
- electron ionization
- SD
- Sprague-Dawley
- AUC
- area under the curve
- Tmax
- time to reach maximum concentration
- Cmax
- maximum plasma concentration
- DDT
- dichlorodiphenyltrichloroethane
- DDE
- 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene
- PCB
- polychlorinated biphenyl
- DCHM
- 2-6-dichloro-4-(3,3-dichloroprop-2-enyloxy)phenol
- S-1812-Py-OH
- 2-(3-(2,6-dichloro-4-(3,3-dichloroprop-2-enyloxy)phenoxy)propoxy)-3-hydroxy-5-(trifluoromethyl)pyridine
- S-1812-DP
- 3,5-dichloro-4-(3-(5-trifluoromethyl-2-pyridyloxy)propoxy)phenol.
- Received June 8, 2009.
- Accepted September 16, 2009.
- Copyright © 2009 by The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|